Article
Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma.
PloS one - 1 Jan 2016
Jóna Ádám, Miltényi Zsófia, Póliska Szilárd, Bálint Bálint László, Illés Árpád
Abstract excerpt
BACKGROUND: Bleomycin hydrolase (BLMH), an enzyme that inactivates bleomycin, may be a potential candidate that could influence pulmonary function in ABVD (doxorubicin, bleomycin, vinblastin, dacarbasine)-treated Hodgkin lymphoma (HL) patients. PATIENTS AND METHODS: We hypothesized that the BLMH gene SNP A1450G (rs1050565) influences BLMH activity and late pulmonary toxicity. St. George Respiratory Questionnaire,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
